North Rock Partners, LLC Astrazeneca PLC Transaction History
North Rock Partners, LLC
- $4.99 Billion
- Q3 2025
A detailed history of North Rock Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, North Rock Partners, LLC holds 4,466 shares of AZN stock, worth $399,260. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,466
Previous 4,572
2.32%
Holding current value
$399,260
Previous $319,000
7.21%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,517Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...